Revvity
Supplies research tools, scientific software, and clinical diagnostics from discovery through screening.
$127.20
After-hours close−1.61 (−1.25%)
At close$128.81(−0.69%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | $1.28 | — | — |
| Aug 2026 | $1.21 | $1.41 | +16.5% |
| May 2026 | $1.02 | $1.06 | +3.9% |
| Feb 2026 | $1.57 | $1.70 | +8.3% |
| Oct 2025 | $1.14 | $1.18 | +3.5% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| Apr 2025 | |||
| Jan 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Oct 26, 2026 | $1.28 | — | — | $694.1M | — | — |
| Aug 4, 2026 | $1.21 | $1.41 | +16.5% | $703.0M | $711.0M | +1.1% |
| May 5, 2026 | $1.02 | $1.06 | +3.9% | $704.1M | $711.1M | +1.0% |
| Feb 2, 2026 | $1.57 | $1.70 | +8.3% | $764.9M | $772.1M | +0.9% |
| Oct 27, 2025 | $1.14 | $1.18 | +3.5% | $699.4M | $698.9M | −0.1% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Jul 28, 2025 | ||||||
| Apr 28, 2025 | ||||||
| Jan 31, 2025 | ||||||
| Nov 4, 2024 | ||||||
| Jul 29, 2024 | ||||||
| Apr 29, 2024 | ||||||
| Feb 1, 2024 | ||||||
| Oct 30, 2023 | ||||||
| Aug 1, 2023 | ||||||
| May 11, 2023 | ||||||
| Feb 14, 2023 | ||||||
| Oct 2, 2022 | ||||||
| Jul 3, 2022 | ||||||
| Mar 31, 2022 | ||||||
| Dec 31, 2021 | ||||||
| Sep 30, 2021 | ||||||
| Jun 30, 2021 | ||||||
| Mar 31, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||
| Dec 31, 2018 | ||||||
| Sep 30, 2018 | ||||||
| Jun 30, 2018 | ||||||
| Mar 31, 2018 | ||||||
| Dec 31, 2017 | ||||||
| Sep 30, 2017 | ||||||
| Jun 30, 2017 | ||||||
| Mar 31, 2017 | ||||||
| Dec 31, 2016 | ||||||
| Sep 30, 2016 | ||||||
| Jun 30, 2016 | ||||||
| Mar 31, 2016 | ||||||
| Dec 31, 2015 | ||||||
| Sep 30, 2015 | ||||||
| Jun 30, 2015 | ||||||